Author

Jonas Luginbühl

University of Bern

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Dominic Andenmatten· 2 shared Evangelos D. KarousisiD· 2 shared Nino SchwalleriD· 2 shared Aurélien Lalou· 1 shared Emilie Bäumlin· 1 shared Gerardo TurcattiiD· 1 shared Helena BauriD· 1 shared J.-M. VesiniD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

Dominic Andenmatten

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A human cell-free translation screen identifies the NT-2 mycotoxin as a ribosomal inhibitor that binds the peptidyl transferase center

Nino Schwaller, Dominic Andenmatten, Jonas Luginbühl, Julius Rabl, Helena Baur, Marc Chambon, J.-M. Vesin, Gerardo Turcatti, Evangelos D. Karousis

Communications Biology · Sep 23, 2026Peer-reviewedBiochemistry

The Impact of Coronavirus Nsp1 on Host mRNA Degradation Is Independent of Its Role in Translation Inhibition

Emilie Bäumlin, Dominic Andenmatten, Jonas Luginbühl, Aurélien Lalou, Nino Schwaller, Evangelos D. Karousis

This study investigates how SARS-CoV-2 and MERS-CoV Nsp1 proteins affect host mRNA degradation, revealing that Nsp1 binding to ribosomes triggers degradation independently of translation inhibition.

Cell Reports · Mar 29, 2025Peer-reviewedMolecular Biology